Allakos Inc.: Hold Rating Amid Restructuring and Financial Uncertainty

TipRanksMar 17 02:17 ET · Ratings

Allakos GAAP EPS of $0.00

Seeking AlphaMar 12 17:00 ET

Allakos | 10-K: FY2024 Annual Report

SECMar 12 16:11 ET · Announcements

Allakos | 8-K: Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results

SECMar 12 16:09 ET · Announcements

Express News | Allakos Q4 Net Income USD 376 Thousand

ReutersMar 12 16:02 ET

Express News | Allakos Q4 Operating Expenses USD 773 Thousand

ReutersMar 12 16:02 ET

Press Release: Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results

Dow JonesMar 12 16:02 ET

Allakos 4Q Net $376,000 >ALLK

Dow JonesMar 12 16:02 ET

Allakos 4Q EPS 0c >ALLK

Dow JonesMar 12 16:02 ET

Calendar of U.S. Earnings Expected in the Week Ahead

Dow JonesMar 4 06:00 ET

Deal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok

BenzingaJan 31 14:20 ET

Allakos Faces Strategic Uncertainty Following AK006 Phase 1 Trial Failure and Workforce Reduction

TipRanksJan 29 01:15 ET

Allakos Cuts 75% of Workforce After Chronic Hives Trial Failure

Yahoo FinanceJan 28 13:37 ET

Institutional Owners May Consider Drastic Measures as Allakos Inc.'s (NASDAQ:ALLK) Recent US$55m Drop Adds to Long-term Losses

Simply Wall StJan 28 09:32 ET

Hold Rating on Allakos Amid Clinical and Financial Setbacks With AK006

TipRanksJan 28 07:35 ET · Ratings

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaJan 27 16:05 ET

Akero AKRO Phase 2b Success; Allakos ALLK Strategic Alternatives

BioPharmCatalystJan 27 15:50 ET

Why Is Allakos Stock Plunging On Monday?

BenzingaJan 27 14:05 ET

Top Midday Decliners

MT NewswiresJan 27 13:52 ET

Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX) and Allakos (ALLK)

TipRanksJan 27 12:30 ET · Ratings